Rate My Professor Lin Fung

Professor Lin Fung serves as Professor of Medical Laboratory Science in the School of Health at the University of the Sunshine Coast, Queensland, Australia. She earned her PhD in Internal Medicine from the University of Queensland, a Graduate Diploma in Management from Central Queensland University, and a Bachelor of Applied Science in Medical Laboratory Science from RMIT University. As a medical scientist and researcher, she has held management and leadership roles in public and private health sectors, not-for-profit organizations, and Australian universities. Lin Fung leads the OptiBlood translational research team, which focuses on optimizing patient blood use and the collection and application of donated blood. She has secured over A$4.5 million in research grants and supervises four PhD students and one MSc student. Her current projects include investigations into blood donors and donation practices across more than 15 Asian countries, health informatics for blood management in Australian systems in collaboration with The Prince Charles Hospital, blood use in Sweden with Linköping University and Karolinska Institute, and the application of cryopreserved and refrigerated platelets with Australian Red Cross Lifeblood. She holds visiting scholar positions at Sunshine Coast Hospital and Health Service and The Prince Charles Hospital, and engages directly with Metro North and Metro South Hospital and Health Services Blood Management committees to promote evidence-based transfusion practices.

Lin Fung's research specializations encompass transfusion science, patient blood management, mechanisms of transfusion reactions, refrigerated and cryopreserved platelet components, blood donors and donation practices in Asia, evidence-based transfusion in cardiac surgical, orthopedic, and emergency departments, transfusion of older adults, neutrophil immunobiology, transfusion-related acute lung injury (TRALI), and medical laboratory science. She has authored over 80 peer-reviewed publications, including 'Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation' (Critical Care, 2012), 'Protein-bound drugs are prone to sequestration in the extracorporeal membrane oxygenation circuit: results from an ex vivo study' (Critical Care, 2015), 'Transfusion-related acute lung injury (TRALI): current concepts and misconceptions' (Blood Reviews, 2009), 'Outcomes of restrictive versus liberal transfusion strategies in older adults from nine randomised controlled trials: a systematic review and meta-analysis' (The Lancet Haematology, 2017), and 'ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO' (BMC Anesthesiology, 2012). As President-Elect of the International Society of Blood Transfusion (2024-2026), she contributes significantly to the field. Additional roles include editorial board member of Annals of Blood, and memberships in the Australia & New Zealand Society of Blood Transfusion and Haematology Society of Australia & New Zealand. She regularly presents invited lectures at international conferences and fosters collaborations with institutions worldwide.